What is Mariela Mitre's NPI number?

Mariela Mitre's National Provider Identifier (NPI) is 1063918951, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Mariela Mitre's specialty?

Mariela Mitre is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Mariela Mitre located?

Mariela Mitre's practice location on file with NPPES is 360 Essex St Ste 201, Hackensack, NJ 07601-8566.

What is Mariela Mitre's phone number?

The practice phone number listed in the NPPES registry for Mariela Mitre is (551) 996-8660.

Does Mariela Mitre accept Medicare?

Mariela Mitre is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Mariela Mitre's NPI active?

Yes — Mariela Mitre's NPI (1063918951) is active in the NPPES registry as of the last update on 2023-07-05.

IndividualActiveAccepts Medicare

Mariela Mitre, MD, PHD

NPI 1063918951 · Dermatology Physician · Hackensack, NJ

Mariela Mitre, MD, PHD is a Dermatology Physician provider in Hackensack, NJ (NPI 1063918951).

Provider details

NPI number: 1063918951
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: MD, PHD
Sex: Female
Sole proprietor: No

Practice location

360 Essex St Ste 201

Hackensack, NJ 07601-8566

Phone: (551) 996-8660

Street-level locationGet directions

More NJ providers

Mailing address

360 Essex St Ste 201

Hackensack, NJ 07601-8566

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 25MA11424400 (NJ)
Allopathic & Osteopathic Physicians
Student in an Organized Health Care Education/Training Program390200000X
Student, Health Care

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(55/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
8 yrs in NPPES registry
Profile completeness25% of score
83% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
1,154 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	208	$104
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	199	$146
Biopsy of Related Skin Growth, First Growth11102	139	$118
Destruction of Precancer Skin Growth, 2-14 Growths17003	129	$8
Destruction of Precancer Skin Growth, 1 Growth17000	116	$70
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 9 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Mupirocin	69	54
Triamcinolone Acetonide	65	45
Ketoconazole	57	37
Clobetasol Propionate	45	30
Minoxidil	22	—
Prednisone	20	—
Hydrocortisone	19	15
Doxycycline Hyclate	17	12

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$659 across 38 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2018-04-01
Last updated: 2023-07-05
Certified: 2023-07-05

Frequently asked questions

What is Mariela Mitre's NPI number?: Mariela Mitre's National Provider Identifier (NPI) is 1063918951, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Mariela Mitre's specialty?: Mariela Mitre is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Mariela Mitre located?: Mariela Mitre's practice location on file with NPPES is 360 Essex St Ste 201, Hackensack, NJ 07601-8566.
What is Mariela Mitre's phone number?: The practice phone number listed in the NPPES registry for Mariela Mitre is (551) 996-8660.
Does Mariela Mitre accept Medicare?: Mariela Mitre is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Mariela Mitre's NPI active?: Yes — Mariela Mitre's NPI (1063918951) is active in the NPPES registry as of the last update on 2023-07-05.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	208	$104
Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214	199	$146
Biopsy of Related Skin Growth, First Growth11102	139	$118
Destruction of Precancer Skin Growth, 2-14 Growths17003	129	$8
Destruction of Precancer Skin Growth, 1 Growth17000	116	$70
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More

Drug

Part D claims (2024)

Beneficiaries

Mupirocin

Triamcinolone Acetonide

Ketoconazole

Clobetasol Propionate

Minoxidil

—

Prednisone

—

Hydrocortisone

Doxycycline Hyclate

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$659 across 38 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments